Dynavax Technologies Stock Price on November 21, 2024
| DVAX Stock | USD 12.85 0.11 0.85% |
Below is the normalized historical share price chart for Dynavax Technologies extending back to February 19, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Dynavax Technologies stands at 12.85, as last reported on the 17th of December 2024, with the highest price reaching 13.10 and the lowest price hitting 12.83 during the day.
If you're considering investing in Dynavax Stock, it is important to understand the factors that can impact its price. Dynavax Technologies appears to be not too volatile, given 3 months investment horizon. Dynavax Technologies secures Sharpe Ratio (or Efficiency) of 0.1, which denotes the company had a 0.1% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Dynavax Technologies, which you can use to evaluate the volatility of the firm. Please utilize Dynavax Technologies' Coefficient Of Variation of 975.9, mean deviation of 1.57, and Downside Deviation of 2.29 to check if our risk estimates are consistent with your expectations.
Dynavax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of February 2004 | 200 Day MA 11.6009 | 50 Day MA 11.9794 | Beta 1.342 |
Dynavax |
Sharpe Ratio = 0.1026
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DVAX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.39 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Dynavax Technologies is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dynavax Technologies by adding it to a well-diversified portfolio.
Price Book 2.5001 | Enterprise Value Ebitda 30.5727 | Price Sales 6.5322 | Shares Float 113.2 M | Wall Street Target Price 24.6 |
Dynavax Technologies Main Headline on 21st of November 2024
Umoja Biopharma Appoints Scott Myers as Chairman of its Boar... by finance.yahoo.com
SEATTLE, Nov. 21, 2024 -- Umoja Biopharma, Inc. , the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR T-cells, today announced that Scott Myers has been appointed as Chairman of its Board of Directors, succeeding Dieter Weinand who will remain as an advisor. As Umoja evolves to clinical stage with significant upcoming milestones, I look forward to working with Scott as our Board Chairman, said Andrew Sch
Dynavax Technologies Valuation on November 21, 2024
It is possible to determine the worth of Dynavax Technologies on a given historical date. On November 21, 2024 Dynavax was worth 12.26 at the beginning of the trading date compared to the closed value of 12.36. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dynavax Technologies stock. Still, in general, we apply an absolute valuation method to find Dynavax Technologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dynavax Technologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dynavax Technologies' related companies.
| Open | High | Low | Close | Volume | |
| 12.01 | 12.24 | 11.75 | 12.17 | 1,352,755 | |
11/21/2024 | 12.26 | 12.45 | 12.11 | 12.36 | 1,867,903 |
| 12.32 | 12.58 | 12.32 | 12.42 | 902,479 |
| Backtest Dynavax Technologies | | | Dynavax Technologies History | | | Dynavax Technologies Valuation | Previous | Next |
Dynavax Technologies Trading Date Momentum on November 21, 2024
| On November 22 2024 Dynavax Technologies was traded for 12.42 at the closing time. The top price for the day was 12.58 and the lowest listed price was 12.32 . The trading volume for the day was 902.5 K. The trading history from November 22, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.49% . The overall trading delta against the current closing price is 3.56% . |
Dynavax Technologies Fundamentals Correlations and Trends
By evaluating Dynavax Technologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Dynavax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Dynavax Technologies Stock history
Dynavax Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dynavax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dynavax Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dynavax Technologies stock prices may prove useful in developing a viable investing in Dynavax Technologies
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Dynavax Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 311 people.
Dynavax Technologies Quarterly Net Working Capital |
|
Dynavax Technologies Stock Technical Analysis
Dynavax Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Dynavax Technologies Period Price Range
Low | December 17, 2024
| High |
0.00 | 0.00 |
Dynavax Technologies cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Dynavax Technologies December 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Dynavax Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dynavax Technologies shares will generate the highest return on investment. By undertsting and applying Dynavax Technologies stock market strength indicators, traders can identify Dynavax Technologies entry and exit signals to maximize returns
Dynavax Technologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dynavax Technologies' price direction in advance. Along with the technical and fundamental analysis of Dynavax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dynavax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0809 | |||
| Jensen Alpha | 0.1441 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0674 | |||
| Treynor Ratio | 0.2026 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.